The cannabis industry is red hot with mergers and acquisitions, and the medical sector of the market is no exception. A recent Forbes article discussed Pfizer’s purchase of Arena Pharmaceuticals, a biotech company focused on cannabinoid-type therapeutics. They have a promising candidate in development called Olorinab, which is an investigational drug that treats the pain associated with diseases affecting the stomach and intestine.
Pfizer Enters the Medical Cannabis Market
The pharma giant will pay $6.7 billion to acquire a cannabinoid-based bowel disease treatment.
Jan 11, 2022
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Downloads
